Advertisement
The Journal of Heart and Lung Transplantation
International Society for Heart and Lung Transplantation.

Successful treatment of a primary central nervous system lymphoproliferative disorder post-heart transplantation with modification of the immunosuppressive regimen used: A case report

Published:October 21, 2021DOI:https://doi.org/10.1016/j.healun.2021.10.009
      Primary central nervous system posttransplant lymphoproliferative disorder (PCNS-PTLD) is extremely rare, especially after heart transplantation (HTx), and is a fatal disease.
      • Cavaliere R
      • Petroni G
      • Lopes MB
      • Schiff D
      International Primary Central Nervous System Lymphoma Collaborative G
      Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group Report.
      Therefore, an optimal treatment strategy for PCNS-PTLD in HTx recipients is required.

      Abbreviations:

      EBV (Epstein–Barr virus), FDG-PET (18F-fluorodeoxyglucose–positron emission tomography), HTx (heart transplant), MRI (magnetic resonance imaging), PCNS-PTLD (primary central nervous system posttransplant lymphoproliferative disorder)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Heart and Lung Transplantation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Cavaliere R
        • Petroni G
        • Lopes MB
        • Schiff D
        • International Primary Central Nervous System Lymphoma Collaborative G
        Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group Report.
        Cancer. 2010; 116: 863-870
        • Mucha K
        • Foroncewicz B
        • Ziarkiewicz-Wroblewska B
        • Krawczyk M
        • Lerut J
        • Paczek L
        Post-transplant lymphoproliferative disorder in view of the new WHO classification: a more rational approach to a protean disease?.
        Nephrol Dial Transplant. 2010; 25: 2089-2098
        • Asleh R
        • Clavell AL
        • Pereira NL
        • et al.
        Incidence of malignancies in patients treated with sirolimus following heart transplantation.
        J Am Coll Cardiol. 2019; 73: 2676-2688
        • White ML
        • Moore DW
        • Zhang Y
        • Mark KD
        • Greiner TC
        • Bierman PJ
        Primary central nervous system post-transplant lymphoproliferative disorders: the spectrum of imaging appearances and differential.
        Insights Imaging. 2019; 10: 46
        • Lake W
        • Chang JE
        • Kennedy T
        • Morgan A
        • Salamat S
        • Baskaya MK
        A case series of primary central nervous system posttransplantation lymphoproliferative disorder: imaging and clinical characteristics.
        Neurosurgery. 2013; 72: 960-970